These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31435460)

  • 1. Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness.
    Hsu CY; Wang CW; Cheng AL; Kuo SH
    World J Gastrointest Oncol; 2019 Aug; 11(8):579-588. PubMed ID: 31435460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
    Hoegen-Saßmannshausen P; Naumann P; Hoffmeister-Wittmann P; Ben Harrabi S; Seidensaal K; Weykamp F; Mielke T; Ellerbrock M; Habermehl D; Springfeld C; Dill MT; Longerich T; Schirmacher P; Mehrabi A; Chang DH; Hörner-Rieber J; Jäkel O; Haberer T; Combs SE; Debus J; Herfarth K; Liermann J
    JHEP Rep; 2024 Jun; 6(6):101063. PubMed ID: 38737600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
    Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
    J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma.
    Abousaida B; Seneviratne D; Hoppe BS; Ko SJ; Asaithamby A; Cucinotta FA; Kirwan JM; Mody K; Toskich B; Ashman JB; Hallemeier CL; Krishnan S
    J Hepatocell Carcinoma; 2021; 8():1169-1179. PubMed ID: 34595139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient specific outcomes of charged particle therapy for hepatocellular carcinoma - A systematic review and quantitative analysis.
    Spychalski P; Kobiela J; Antoszewska M; Błażyńska-Spychalska A; Jereczek-Fossa BA; Høyer M
    Radiother Oncol; 2019 Mar; 132():127-134. PubMed ID: 30825961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
    Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
    Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Qi WX; Fu S; Zhang Q; Guo XM
    Radiother Oncol; 2015 Mar; 114(3):289-95. PubMed ID: 25497556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis.
    Rim CH; Lee JS; Kim SY; Seong J
    JHEP Rep; 2023 Jan; 5(1):100594. PubMed ID: 36561128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pencil Beam Scanning Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
    Zhang W; Cai X; Sun J; Wang W; Zhao J; Zhang Q; Jiang G; Wang Z
    J Hepatocell Carcinoma; 2023; 10():2397-2409. PubMed ID: 38169909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma.
    Byun HK; Kim C; Seong J
    Clin Mol Hepatol; 2023 Oct; 29(4):945-957. PubMed ID: 37583055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses.
    Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
    Front Oncol; 2020; 10():572493. PubMed ID: 33102230
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic review of publications on charged particle therapy for hepatocellular carcinoma.
    Igaki H; Mizumoto M; Okumura T; Hasegawa K; Kokudo N; Sakurai H
    Int J Clin Oncol; 2018 Jun; 23(3):423-433. PubMed ID: 28871342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
    Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who Will Benefit from Charged-Particle Therapy?
    Kim KS; Wu HG
    Cancer Res Treat; 2021 Jul; 53(3):621-634. PubMed ID: 34176253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
    Apisarnthanarax S; Bowen SR; Combs SE
    Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
    Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
    BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.